PET-FDG Uptake Ratio (Myocarditis Activity) Calculator

Clinical calculation support · Verify results before clinical use

Uptake ratio inputs

Enter SUV measurements from the same PET study and use a consistent region-of-interest method.

— TBR
Maximum standardized uptake value in the target myocardial segment. Must be greater than zero.
Mean SUV in a standardized blood-pool region, avoiding myocardial spill-in where possible.
Leave blank if a suitable remote myocardial reference is not available. This ratio is descriptive and has no universal diagnostic cutoff.

How to interpret the uptake ratios

Cardiac 18F-FDG PET assesses glucose uptake associated with inflammatory-cell activity. Physiologic myocardial uptake must be adequately suppressed before focal uptake can be interpreted as potentially pathologic. Preparation, image acquisition, reconstruction, scanner characteristics, and region-of-interest placement can substantially affect SUV measurements.

This calculator reports a descriptive target-to-background ratio (TBR), calculated as target myocardial SUVmax divided by blood-pool SUVmean. If a remote myocardial SUVmean is entered, it also reports a target-to-normal myocardium ratio (TNR). These ratios are not interchangeable with every published myocardium-to-background metric; published studies may use different target statistics, background regions, or acquisition protocols.

Calculation and reporting

ParameterDefinitionImportant limitation
TBRMyocardial SUVmax / blood-pool SUVmeanDepends on background ROI and imaging protocol.
TNRTarget myocardial SUVmax / remote myocardial SUVmeanOnly meaningful when a suitable remote reference is available; physiologic uptake may be heterogeneous.

Practical considerations

  • Follow the local cardiac FDG-PET preparation protocol to suppress physiologic myocardial uptake; document preparation and image quality.
  • Use a predefined, reproducible blood-pool ROI and avoid spill-in from adjacent structures where possible.
  • Interpret focal or diffuse uptake in the context of the clinical phenotype, image quality, and other investigations, including CMR when appropriate.
  • For serial studies, compare measurements only when acquisition, preparation, reconstruction, and ROI methods are sufficiently comparable.

Evidence and references

Chareonthaitawee P, et al. Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. Journal of Nuclear Medicine. 2017;58(8):1341–1353. doi:10.2967/jnumed.117.196287
Martineau P, et al. Assessing cardiovascular infection and inflammation with FDG-PET. This reference was listed in the source template; exact bibliographic details were not independently confirmed for this redesign.
Myocarditis-specific thresholds No universal TBR or TNR diagnostic threshold is established here for myocarditis. Values near 2.0–2.1 cited in the original code should not be applied as a general myocarditis cutoff without confirming the exact study, cohort, and measurement method.
Clinical disclaimer: This tool performs arithmetic on entered SUV values; it does not diagnose myocarditis or cardiac sarcoidosis. No category or treatment recommendation should be based on TBR/TNR alone. Uptake must be interpreted by an appropriately trained clinician using the acquisition protocol, preparation adequacy, clinical presentation, and complementary imaging and laboratory findings.